
Illustration: Reuters
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Topics
AstraZeneca | Pharma sector | Companies

Illustration: Reuters
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
AstraZeneca Pharma India on Wednesday said Gagandeep Singh Bedi has resigned from the post of managing director.
The drug firm said it has approved the appointment of Sanjeev Panchal as its managing director for a period of three years with effect from January 1, 2023.
Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK), it said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Wed, December 14 2022. 21:58 IST
Coutts steps into private marketsCoutts, the private bank best known for serving Britain’s wealthiest families and the... Read more
How Crypto Moved from the Wild West to the Mainstream Financial SystemA long-form analysis of Bitcoin's journey from fri... Read more
ACB Securities: Building Scale, Trust and Innovation in Vietnam’s Capital MarketsACB Securities (ACBS) is emerging as ... Read more
For most of the past year, global markets behaved as though geopolitical risk had largely disappeared. Inflation was eas... Read more
The payments system is undergoing a quiet but consequential shift. What was once the exclusive preserve of central banks... Read more
The Bank of England has taken a significant step towards easing post-crisis regulation by lowering its estimate of the c... Read more